Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeneFIX PK Comparison in Severe Hemophilia B
NCT03091751Phase 2Completed
- Sponsor
- Grifols
- Start
- Aug 2005
- Primary completion
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of coagulation factor IX human in hemophilia B (HB), sponsored by Grifols. Primary endpoints: Area Under the Curve at 74 hours, In Vivo Recovery at 74 hours and 3 more. Started Aug 2005; status: completed.
02
Drugs
coagulation factor IX human
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT03091751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091751.